PIG-L chemical inhibitiors like Tunicamycin and Kifunensine disrupt N-linked glycosylation and mannose trimming, respectively, which are steps crucial for the proper folding and function of many glycoproteins. By inhibiting these steps, these chemicals can lead to the accumulation of misfolded proteins and exert stress on the endoplasmic reticulum (ER), which could impact proteins that are reliant on these pathways for their maturation and function. Disruption of glycosylation can have widespread effects on cellular functions, potentially including the modulation of proteins like PIG-L.
Another aspect of PIG-L Inhibitors involves the disruption of intracellular transport and signaling pathways. Compounds such as Brefeldin A and Monensin interfere with protein trafficking between the ER and the Golgi apparatus, which is a critical pathway for the processing and sorting of secretory and membrane proteins. By inhibiting these pathways, the inhibitors might affect the proper localization and function of proteins that are dependent on ER-Golgi trafficking. On the level of cellular homeostasis and signaling, chemicals such as Thapsigargin and Cyclopiazonic Acid inhibit calcium pumps, leading to alterations in cytosolic calcium levels, which is a second messenger in many signaling pathways. These changes can have broad effects on cellular activities and potentially influence proteins associated with calcium signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
An inhibitor of Golgi alpha-mannosidase II, potentially affecting glycoprotein synthesis. | ||||||
Decylubiquinone | 55486-00-5 | sc-358659 sc-358659A | 10 mg 50 mg | $70.00 $269.00 | 10 | |
A ubiquinone analog that can inhibit mitochondrial electron transport, affecting cellular energetics. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A fungal metabolite that inhibits protein transport from the ER to the Golgi apparatus. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An inhibitor of N-linked glycosylation, which can disrupt protein folding and trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts Golgi function, which could indirectly affect proteins processed in the Golgi. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
An inhibitor of glucosidases, which may disrupt glycoprotein processing and maturation. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
A glucosidase inhibitor that can alter glycosylation patterns and interfere with glycoprotein maturation. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
An inhibitor of mannosidase I in the ER, potentially affecting N-glycan processing. | ||||||
N-Butyldeoxynojirimycin·HCl | 210110-90-0 | sc-201398 sc-201398A sc-201398B | 5 mg 25 mg 50 mg | $180.00 $550.00 $985.00 | 4 | |
An iminosugar that inhibits glycosphingolipid biosynthesis, potentially affecting membrane composition. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A GTPase inhibitor that can disrupt endocytosis and vesicular trafficking pathways. | ||||||